USFDA issues warning letter to Cipla for Goa manufacturing facility
Posted by
www.biotecnika.org
Drug firm Cipla Ltd said that the US health regulator has issued a
warning letter to the company for its manufacturing facility in Goa.
The company further said that it remains committed to maintain highest
standards of compliance and will work closely with the agency to
comprehensively address all the observations.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-issues-warning-letter-to-cipla-for-goa-manufacturing-facility/articleshow/74312928.cms
Subscribe to:
Post Comments (Atom)
Post a Comment